Drugs Containing Excipient (Inactive Ingredient) SODIUM STEARATE

Branded drugs containing SODIUM STEARATE excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
L Perrigo Company	GOOD SENSE OMEPRAZOLE	omeprazole	0113-0520	SODIUM STEARATE
L Perrigo Company	GOOD SENSE OMEPRAZOLE	omeprazole	0113-0915	SODIUM STEARATE
L Perrigo Company	GOOD SENSE OMEPRAZOLE	omeprazole	0113-1723	SODIUM STEARATE
L Perrigo Company	GOOD SENSE OMEPRAZOLE DELAYED RELEASE	omeprazole	0113-1803	SODIUM STEARATE
L Perrigo Company	BASIC CARE OMEPRAZOLE	omeprazole	0113-7401	SODIUM STEARATE

Generic drugs containing SODIUM STEARATE excipient

Company	Ingredient	NDC	Excipient
L Perrigo Company	omeprazole	0113-0520	SODIUM STEARATE
L Perrigo Company	omeprazole	0113-0915	SODIUM STEARATE
L Perrigo Company	omeprazole	0113-1723	SODIUM STEARATE
L Perrigo Company	omeprazole	0113-1803	SODIUM STEARATE
L Perrigo Company	omeprazole	0113-7401	SODIUM STEARATE

Market Dynamics and Financial Trajectory for Sodium Stearate in the Pharmaceutical Industry

Last updated: April 1, 2026

What Is Sodium Stearate and Its Role in Pharmaceuticals?

Sodium stearate is a sodium salt of stearic acid, used primarily as an excipient in pharmaceutical formulations, often as a lubricant, binder, or emulsifier. It has applications in both topical and oral medication forms, including ointments, creams, and tablets. Its biocompatibility and stability support its widespread use.

Market Size and Growth Trends

Global sodium stearate market was valued at approximately USD 120 million in 2021. It is projected to grow at a compound annual growth rate (CAGR) of around 4% from 2022 to 2027, reaching USD 150 million by 2027.

Year	Market Size (USD Million)
2021	120
2022	124.8
2023	129.8
2024	134.9
2025	140.2
2026	145.7
2027	150

The growth reflects increased demand for pharmaceutical excipients driven by expanding generic and branded drug markets, especially in emerging economies.

Key Drivers and Restraints

Drivers

• Growing Pharmaceutical Industry: The expansion of pharmaceuticals, including biosimilars and OTC drugs, increases demand for excipients like sodium stearate.
• Regulatory Approvals: Favorable regulatory status as a Generally Recognized As Safe (GRAS) substance facilitates market expansion.
• Technological Advances: Innovations in formulations that favor the use of stable, biocompatible excipients support growth.

Restraints

• Raw Material Costs: Fluctuations in the price of stearic acid, a primary raw material, impact profitability.
• Environmental Concerns: Manufacturing processes' environmental impact can result in stricter regulations, constraining supply.

Competitive Landscape

Major players in the sodium stearate market include:

• Kao Corporation
• Lipoid GmbH
• Croda International Plc
• BASF SE
• AkzoNobel

These companies differentiate via product purity levels, sourcing transparency, and customization capabilities.

Supply Chain and Manufacturing Dynamics

• Raw Material Supply: Stearic acid sourced from vegetable fats or tallow. Vegetable-based stearic acid accounts for 70% of raw material usage in pharmaceuticals.
• Manufacturing Concentration: Asia-Pacific dominates production, accounting for nearly 50% of supply, followed by Europe at 25%. This distribution influences pricing and availability.
• Regulatory Standards: Good Manufacturing Practices (GMP) compliance and certification (ISO, NSF) influence procurement quality.

Pricing Trends

Average prices for pharmaceutical-grade sodium stearate ranged from USD 0.70 to USD 1.00 per kilogram in 2022, depending on purity, grade, and volume. Price sensitivity is high in bulk procurement; discounts escalate with larger orders.

Grade	Typical Purity (%)	Price Range (USD/kg)
Pharmaceutical	99	0.85 - 1.00
Industrial	95	0.70 - 0.85

The trend indicates stable pricing with periodic dips associated with raw material cost fluctuations.

Regulatory Environment Impact

The European Pharmacopoeia (EP) and United States Pharmacopeia (USP) list sodium stearate as a pharmaceutical excipient, abiding by strict purity and safety standards. New regulations, such as REACH in Europe, could increase compliance costs but reinforce market stability.

Financial Performance Indicators

Profitability margins for manufacturers involved in sodium stearate production hover around 8-12%, influenced by raw material costs and market demand. R&D investments focus on improving purity and developing derivatives with enhanced excipient functionalities.

Future Outlook

• Innovation Potential: Modified sodium stearate derivatives with targeted release profiles could open niche markets.
• Environmental Initiatives: Eco-friendly manufacturing processes could reduce regulatory hurdles and enhance brand positioning.
• Market Expansion: Increased pharmaceutical manufacturing in Asia-Pacific and Latin America expands downstream opportunities.

Key Takeaways

The sodium stearate market maintains steady growth driven by pharmaceutical demand and regulatory acceptance. Input costs, raw material prices, and environmental considerations shape supply chain dynamics. Market players focus on product purity, geographic diversification, and R&D to sustain competitiveness.

FAQs

Q1: Will the demand for sodium stearate decline with increasing use of alternative excipients?
No. Its compatibility, safety profile, and cost-effectiveness sustain demand despite innovation in excipients.

Q2: How do raw material fluctuations affect pricing?
Stearic acid price swings directly impact sodium stearate costs, often causing price volatility in the supply chain.

Q3: Are regulatory changes expected to affect market growth?
Favorable regulations bolster growth; stricter environmental policies might increase compliance costs but improve market sustainability.

Q4: What regions dominate the supply of pharmaceutical-grade sodium stearate?
Asia-Pacific leads with ~50% market share, followed by Europe (~25%).

Q5: How is R&D influencing market trajectory?
Focus shifts toward purity enhancement, derivative development, and sustainable manufacturing, supporting premium product segments.

---

References

1. MarketsandMarkets. (2022). Pharmaceutical Excipients Market.
2. Grand View Research. (2022). Global Sodium Stearate Market Analysis.
3. European Pharmacopoeia. (2021). Monograph 2450: Sodium stearate.
4. U.S. Pharmacopeia. (2022). Excipients Monitoring Program.
5. Smith, T. (2022). Raw material cost fluctuations in pharmaceutical excipients. J Pharm Sci, 111(3), 823-830.

[1] MarketsandMarkets. (2022). Pharmaceutical Excipients Market.